ID: ALA3678075

Max Phase: Preclinical

Molecular Formula: C15H24N2O2

Molecular Weight: 264.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCOc1cccc(CCNCC(=O)NC)c1

Standard InChI:  InChI=1S/C15H24N2O2/c1-3-4-10-19-14-7-5-6-13(11-14)8-9-17-12-15(18)16-2/h5-7,11,17H,3-4,8-10,12H2,1-2H3,(H,16,18)

Standard InChI Key:  KZUXGKZWVDBSGE-UHFFFAOYSA-N

Associated Targets(non-human)

Monoamine oxidase B 2209 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 264.37Molecular Weight (Monoisotopic): 264.1838AlogP: 1.74#Rotatable Bonds: 9
Polar Surface Area: 50.36Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.61CX LogP: 1.88CX LogD: 0.65
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.67Np Likeness Score: -1.03

References

1.  (2015)  Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators, 

Source

Source(1):